» Authors » Concepcion F Guillamon

Concepcion F Guillamon

Explore the profile of Concepcion F Guillamon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 43
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pons-Fuster E, Bernal E, Guillamon C, Gimeno L, Martinez-Sanchez M, Ruiz-Lorente I, et al.
Infect Dis (Lond) . 2024 May; 56(10):818-829. PMID: 38743055
Background: HIV-1-associated neurocognitive disorders (HAND) in stable patients undergoing antiretroviral therapy (ART) may result from ongoing immune dysregulation and chronic inflammation. A contributing factor may result from the unstable HLA...
2.
Guillamon C, Gimeno L, Server G, Martinez-Sanchez M, Escudero J, Lopez-Cubillana P, et al.
Eur Urol Oncol . 2019 Aug; 4(2):246-255. PMID: 31411976
Background: Bladder cancer (BC) is highly immunogenic. Bacillus Calmette-Guérin (BCG) immunotherapy offers the best results in non-muscle-invasive BC (NMIBC). Natural killer cells (NKcs) play decisive roles in BCG-mediated immune response...
3.
Guillamon C, Martinez-Sanchez M, Gimeno L, Campillo J, Server-Pastor G, Martinez-Garcia J, et al.
Cancer Immunol Res . 2019 Jun; 7(8):1307-1317. PMID: 31239317
Therapies using NK cells (NKc) expanded/activated or stimulated with new immunostimulatory agents offer alternative opportunities for patients with recurrent/refractory tumors, but relevant biomarkers to guide the selection of patients are...
4.
Bernal E, Martinez M, Torres A, Guillamon C, Alcaraz A, Alcaraz M, et al.
Antiviral Res . 2018 Dec; 162:163-170. PMID: 30593833
The main objective of this study is to evaluate the predictive capacity of T cell activation/senescence in subclinical atherosclerosis (SCA) in a group of HIV-infected patients. So, a cross-sectional analysis...
5.
Guillamon C, Martinez-Sanchez M, Gimeno L, Mrowiec A, Martinez-Garcia J, Server-Pastor G, et al.
Cancer Immunol Res . 2018 Sep; 6(12):1537-1547. PMID: 30242020
Natural killer cell (NKc)-based therapies offer promising outcomes in patients with tumors, but they could improve with appropriate selection of donors and optimization of methods to expand NKcs Education through...